about
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trialsSarcopenia: pharmacology of today and tomorrowRecommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaMelatonin as a Potential Agent in the Treatment of SarcopeniaSarcopenia and the analysis of body composition.Sarcopenia in older adultsDesigning pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility.Reproducibility of jumping mechanography and traditional measures of physical and muscle function in older adults.Abnormal myofiber morphology and limb dysfunction in claudication.Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on SarcopeniaTranslational musculoskeletal science: is sarcopenia the next clinical target after osteoporosis?What's in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?".Myostatin--the holy grail for muscle, bone, and fat?Techniques for the diagnosis of sarcopenia.Physical frailty and sarcopenia (PF&S): a point of view from the industry.Physical activity, diet quality, and mortality among sarcopenic older adults.How do we define and measure sarcopenia? Protocol for a systematic review.Sarcopenia and osteopenia among 70-80-year-old home-dwelling Finnish women: prevalence and association with functional performance.Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).Presarcopenia and sarcopenia in hip-fracture women: prevalence and association with ability to function in activities of daily living.Body composition, muscle strength, and physical function of patients with Bethlem myopathy and Ullrich congenital muscular dystrophy.
P2860
Q27022354-113930AE-7F6E-47B1-81A3-0545ABD9DAB4Q27687696-CDCB7EDA-CED4-40E9-A382-F13B2D7D2496Q28069408-833F2872-7BCB-4C9E-90DD-45E5C5B0376EQ28076649-1B1E3953-478E-4610-B419-849E264CEBE5Q33578662-CEFCA5B3-AEEA-4CAA-8EAD-969684D76129Q33789846-D0526A2B-DEEC-4A10-AAC5-D5F0CED9A158Q33828935-88079AAD-57DC-435C-988E-74883CEC346EQ34156968-A3E49379-2A47-4B0B-A133-5CF9B95F7C5DQ34452757-5FE42A6F-CCA1-47B6-BB31-9EDEC60E47D3Q35882665-BD909FC7-51BA-4278-AA06-E1656C4F6AD2Q36179100-403F2019-50E5-421C-8EBF-F619FFEE23A8Q37955979-F2C71E17-6E69-4D91-A8AF-7D1CA061973EQ38125618-F9894E6F-8755-477C-9612-C417F58FCCCFQ38144994-191A7530-02C3-4200-9F16-90DC6B0981F7Q38311083-6D925A95-D266-45C3-9DBF-C1A52F346277Q39119188-053979FA-6CAC-4400-BD1F-D9E15A45B11BQ40830339-512FD404-753F-4488-A348-5567525019ABQ51733789-C04CF075-DCA7-4508-951A-0D06FF506A82Q53128701-E9A33ECF-B931-461A-BBDB-1C8AC2EB18F8Q53139969-D8BCCBD7-8BA6-4A55-A832-88092E32E3B5Q53342027-D3F73B1D-9679-4D9D-8E99-4B5A32667102Q54690359-35F77580-9405-41E7-8F62-409A25861E29
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Sarcopenia: designing phase IIB trials
@ast
Sarcopenia: designing phase IIB trials
@en
type
label
Sarcopenia: designing phase IIB trials
@ast
Sarcopenia: designing phase IIB trials
@en
prefLabel
Sarcopenia: designing phase IIB trials
@ast
Sarcopenia: designing phase IIB trials
@en
P2093
P2860
P1476
Sarcopenia: designing phase IIB trials
@en
P2093
International Working Group on Sarcopenia Task Force Members
L Ferrucci
R A Fielding
S Studenski
Wm C Chumlea
P2860
P2888
P304
P356
10.1007/S12603-011-0092-7
P577
2011-06-01T00:00:00Z